e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) November 27, 2009
NOVAVAX, INC.
(Exact name of Registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
0-26770
|
|
22-2816046 |
| (State or other jurisdiction of incorporation or
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.) |
| organization) |
|
|
|
|
| |
|
|
| 9920 Belward Campus Drive
|
|
|
| Rockville, Maryland
|
|
20850 |
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (240) 268-2000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Arrangements of Certain Officers.
On November 27, 2009, the Board of Directors of Novavax, Inc. (the “Company”) determined that the
roles of principal financial officer and principal accounting officer should be held by one
individual. Accordingly, Evdoxia E. Kopsidas was relieved of her duties as principal accounting
officer, and Frederick W. Driscoll, the Company’s Vice President, Chief Financial Officer and
Treasurer, was appointed the Company’s principal accounting officer, effective immediately.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned, thereunto duly authorized
| |
|
|
|
|
| |
Novavax, Inc.
(Registrant)
|
|
| December 1, 2009 |
By: |
/s/ Frederick W. Driscoll
|
|
| |
Name: |
Frederick W. Driscoll |
|
| |
Title: |
Vice President, Chief Financial Officer and
Treasurer |
|
| |